Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has begun prescribing through the new Medicare GLP-1 Bridge Program, a new demonstration program ...

To qualify for the Medicare Bridge program, you must have Medicare Part D, meet clinical eligibility, and have a prescription for an eligible GLP-1 medication. This medication must be used alongside ...

Medicare's GLP-1 Bridge program launches July 1, offering $50 copays for weight loss drugs like Wegovy and Zepbound. Check ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The ...

The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part ...

Pharmacists can help answer questions about eligibility requirements, participating medications, prior authorization ...

CMS is rolling out the Medicare GLP-1 Bridge program — a demonstration designed to give eligible Medicare Part D beneficiaries access to certain GLP-1s at a fixed monthly cost — July 1. CMS officials, ...